Naltrexone HCl/bupropion HCl

DRUG2 trials

Sponsors

Takeda, Orexigen Therapeutics, Inc

Conditions

Heart RepolarizationWeight Regain Post Bariatric Surgery

Phase 1

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

CompletedNCT02735603

Orexigen Therapeutics, IncHeart Repolarization

Start: 2016-04-30End: 2016-10-31Updated: 2016-11-01

Phase 4

Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

WithdrawnNCT02616315

TakedaWeight Regain Post Bariatric Surgery

Start: 2016-02-29End: 2017-12-31Updated: 2016-04-08